Vector BioPharma
PrivateLast Round
Series A
Aug 10, 2022
Total Funding Raised
$30M
Company Overview
Vector BioPharma is a biotechnology company that develops a precision gene delivery platform utilizing engineered adenoviral vectors for cell- and tissue-specific delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vector BioPharma Comparables
Compare Vector BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera | 84% | |
| Nvelop Therapeutics | 83% | |
| Anjarium Biosciences | 83% | |
Vector BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 10, 2022 |
Vector BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A |
Vector BioPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vector BioPharma's valuation, stock price, and market status.